The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Sat., Feb. 29, 12:35 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #17. Quest Diagnostics Solstas Lab Partners

Acquirer: Quest Diagnostics (NYSE:DGX)
Acquiree: Solstas Lab Partners
Details: Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously announced acquisition of Solstas Lab Partners Group and its subsidiaries (Solstas), a full-service commercial laboratory company based in Greensboro, North Carolina. The combination of Solstas with Quest Diagnostics will give patients and healthcare providers in the Southeastern United States, where Solstas operates in nine states, including the Carolinas, Virginia, Tennessee, Georgia and Alabama, greater access to innovative and cost-effective diagnostic information services.

Quest Diagnostics provides diagnostic information services. Co.'s diagnostic information segment provides information based on the menu of routine, non-routine and clinical testing and anatomic pathology testing, and other diagnostic information services. Co.'s testing capabilities, includes services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and provides tests in several fields, including endocrinology, immunology, neurology and oncology. Co.'s diagnostic solutions provides risk assessment services for the life insurance industry, as well as provides healthcare organizations and clinicians health information technology solutions.

Quest Diagnostics SEC Filing Email Alerts Service


Open the DGX Page at The Online Investor »

Company Name: 
Quest Diagnostics, Inc.
Stock buyback: 
DGX buyback
Website: 
www.QuestDiagnostics.com
Sector: 
Diagnostics
Number of ETFs Holding DGX: 
95
Total Market Value Held by ETFs: 
$1.92B
Total Market Capitalization: 
$14.67B
% of Market Cap. Held by ETFs: 
13.11%
 

Open the DGX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (2.58 out of 4)
21st percentile
(ranked lower than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 17 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.